Summary
Censa Pharmaceuticals is a biopharmaceutical company focused on the development of CNSA-001 (sepiapterin), a clinical-stage investigational therapy for orphan metabolic diseases.
Deals Overview
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite
Senior Management
Jonathan Reis
President and CEO